.
  • NIFTY 24,712.05 -255.70 (-1.02%)
  • SENSEX 80,786.54 -849.37 (-1.04%)
 
BSE
NSE

Tuesday, August 26, 2025 , BSE Sensex : 80,786.54 80,786.54(-1.04%) , Adani Ports : 1,315.50 1,315.50(-1.85%) , Asian Paints : 2,487.45 2,487.45(-0.21%) , Axis Bank : 1,050.15 1,050.15(-1.86%) , Bajaj Finance : 876.50 876.50(-2.67%) , Bajaj Finserv : 1,924.20 1,924.20(-2.00%) , Bharat Electron : 365.85 365.85(-1.65%) , Bharti Airtel : 1,905.40 1,905.40(-1.31%) , Eternal Ltd : 317.80 317.80(-0.49%) , HCL Technologies : 1,492.25 1,492.25(-0.82%) , HDFC Bank : 973.05 973.05(-0.94%) , Hind. Unilever : 2,692.10 2,692.10(2.38%) , ICICI Bank : 1,416.70 1,416.70(-1.15%) , Infosys : 1,529.85 1,529.85(-0.18%) , ITC : 403.10 403.10(0.93%) , Kotak Mah. Bank : 1,965.30 1,965.30(-0.92%) , Larsen & Toubro : 3,539.60 3,539.60(-1.76%) , M & M : 3,330.90 3,330.90(-2.02%) , Maruti Suzuki : 14,711.30 14,711.30(1.75%) , NTPC : 333.25 333.25(-1.36%) , Power Grid Corpn : 279.80 279.80(-1.53%) , Reliance Industr : 1,385.30 1,385.30(-1.95%) , SBI : 807.80 807.80(-0.94%) , Sun Pharma.Inds. : 1,600.45 1,600.45(-3.40%) , Tata Motors : 681.55 681.55(-0.75%) , Tata Steel : 155.00 155.00(-2.88%) , TCS : 3,156.25 3,156.25(0.49%) , Tech Mahindra : 1,502.20 1,502.20(-1.61%) , Titan Company : 3,592.90 3,592.90(-1.62%) , Trent : 5,292.60 5,292.60(-2.45%) , UltraTech Cem. : 12,608.35 12,608.35(0.03%) ,

Nifty 50 : 24,712.05 -255.70(-1.02%) , Adani Enterp. : 2,272.00 -30.90(-1.34%) , Adani Ports : 1,315.40 -25.00(-1.87%) , Apollo Hospitals : 7,793.50 -57.50(-0.73%) , Asian Paints : 2,481.40 -11.50(-0.46%) , Axis Bank : 1,050.10 -19.90(-1.86%) , Bajaj Auto : 8,691.50 -59.00(-0.67%) , Bajaj Finance : 876.25 -24.55(-2.73%) , Bajaj Finserv : 1,924.20 -39.60(-2.02%) , Bharat Electron : 365.85 -6.20(-1.67%) , Bharti Airtel : 1,904.70 -26.00(-1.35%) , Cipla : 1,579.80 -21.40(-1.34%) , Coal India : 372.45 -7.55(-1.99%) , Dr Reddy's Labs : 1,263.20 -20.70(-1.61%) , Eicher Motors : 6,151.00 160.50(2.68%) , Eternal Ltd : 317.90 -1.35(-0.42%) , Grasim Inds : 2,796.20 -15.20(-0.54%) , HCL Technologies : 1,492.80 -11.40(-0.76%) , HDFC Bank : 973.40 -8.65(-0.88%) , HDFC Life Insur. : 776.60 -10.40(-1.32%) , Hero Motocorp : 5,073.40 9.60(0.19%) , Hind. Unilever : 2,692.60 61.00(2.32%) , Hindalco Inds. : 705.70 -10.15(-1.42%) , ICICI Bank : 1,416.60 -16.60(-1.16%) , IndusInd Bank : 756.40 -14.45(-1.87%) , Infosys : 1,529.60 -2.50(-0.16%) , ITC : 403.35 4.00(1.00%) , Jio Financial : 315.75 -3.95(-1.24%) , JSW Steel : 1,047.10 -10.70(-1.01%) , Kotak Mah. Bank : 1,965.70 -17.60(-0.89%) , Larsen & Toubro : 3,541.30 -61.80(-1.72%) , M & M : 3,330.80 -68.10(-2.00%) , Maruti Suzuki : 14,714.00 262.00(1.81%) , Nestle India : 1,162.20 9.20(0.80%) , NTPC : 333.20 -4.65(-1.38%) , O N G C : 234.19 -2.57(-1.09%) , Power Grid Corpn : 279.90 -4.25(-1.50%) , Reliance Industr : 1,384.90 -27.70(-1.96%) , SBI : 807.85 -8.60(-1.05%) , SBI Life Insuran : 1,816.60 -30.20(-1.64%) , Shriram Finance : 594.70 -26.15(-4.21%) , Sun Pharma.Inds. : 1,600.30 -56.40(-3.40%) , Tata Consumer : 1,079.90 -1.70(-0.16%) , Tata Motors : 681.65 -5.15(-0.75%) , Tata Steel : 155.03 -4.60(-2.88%) , TCS : 3,157.20 16.60(0.53%) , Tech Mahindra : 1,502.20 -24.90(-1.63%) , Titan Company : 3,594.00 -57.40(-1.57%) , Trent : 5,295.00 -128.00(-2.36%) , UltraTech Cem. : 12,610.00 4.00(0.03%) , Wipro : 252.03 -1.81(-0.71%) , Tuesday, August 26, 2025

Home >> Markets >> Equities >> News - News Details
DAILY MARKET TRACKER
MARKET ANALYSIS
NEWS
CORPORATE INFO
CORPORATE ACTIONS
OTHER MARKETS
Hot Pursuit
19-Aug-2025     12:11
Glenmark Pharma's US arm to launch Micafungin injection in the US market
The product is bioequivalent and therapeutically equivalent to the reference listed drug Mycamine for Injection, 50 mg/vial and 100 mg/vial, originally developed by Astellas Pharma US, Inc. The company will begin distribution in September 2025.

According to IQVIA sales data for the 12-month period ending June 2025, the U.S. market for Mycamine for Injection generated annual sales of approximately $60.7 million.

Micafungin is an echinocandin antifungal used primarily in the treatment of candidemia, esophageal candidiasis, and for prophylaxis of Candida infections in patients undergoing hematopoietic stem cell transplantation.

Marc Kikuchi, president & business head, North America said, 'We are excited to announce the launch of Micafungin for Injection USP, 50 mg/vial and 100 mg/vial (Single-Dose Vial), growing our portfolio of products within the institutional channel, while also strengthening our commitment to bring quality and affordable alternatives to market for patients in need.' Glenmark's Micafungin for Injection USP, 50 mg/vial and 100 mg/vial (Single-Dose Vial) is only approved for the indication listed in Glenmark's approved label. All brand names and trademarks are the property of their respective owners. Market includes brand and all available therapeutic equivalents. Note: IQVIA data obtained by Glenmark is only available for all approved RLD indications. Glenmark's product is only approved for the indications listed in Glenmark's approved label and is not marketed for all RLD indications. IQVIA National Sales Perspectives: Retail & Non-Retail, June 2025.

Glenmark Pharmaceuticals is a research-led, global pharmaceutical company, having a presence across Branded, Generics, and OTC segments; with a focus on therapeutic areas of respiratory, dermatology and oncology.

The company's consolidated net profit jumped 49.9% to Rs 215.48 crore on 7.4% rise in revenue from operations to Rs 1505.62 crore in Q1 FY26 over Q1 FY25.

The scrip declined 1.38% to Rs 1,947.10 on the BSE.

Powered by Capital Market - Live News